NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

Introduction to "Economic Dimensions of Personalized and Precision Medicine"

Ernst R. Berndt, Dana P. Goldman, John W. Rowe

Chapter in NBER book Economic Dimensions of Personalized and Precision Medicine (2019), Ernst R. Berndt, Dana P. Goldman, and John W. Rowe, editor (p. 1 - 7)
Conference held September 13-14, 2017
Published in April 2019 by University of Chicago Press
© 2019 by the National Bureau of Economic Research

This chapter is no longer available for free download, since the book has been published. To obtain a copy, you must buy the book.
Order from Amazon.com

Machine-readable bibliographic record - MARC, RIS, BibTeX

Users who downloaded this chapter also downloaded* these:
Philipson The Economic Value and Pricing of Personalized Medicine
Pulk, Graham, Lichtenberg, Maeng, Williams, and Wright The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger
Gorry and Useche Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
Chandra, Garthwaite, and Stern Characterizing the Drug Development Pipeline for Precision Medicines
Graves, Zhou, Garbett, and Peterson The Value of Pharmacogenomic Information
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us